Article Per Year (5 Year)
p-Index From 2020 - 2025
0.751
P-Index
This Author published in this journals
All Journal Oeconomicus Journal of Economics Mabsya : Jurnal Manajemen Bisnis Syariah
Fadlullah Hana, Kharis
Unknown Affiliation
Religion Economics, Econometrics & Finance Environmental Science Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Pengaruh Pelaksanaan Pemilu Presiden Indonesia Tahun 2019 Terhadap Return Saham JII70 di Indonesia Adevia Fendiyani, Erika; Zulia Kunthi, Dewi; Fadlullah Hana, Kharis
OECONOMICUS Journal of Economics Vol. 4 No. 2 (2020): (Juni) edisi 8
Publisher : Program Studi Ilmu Ekonomi UIN Sunan Ampel Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15642/oje.2020.4.2.146-168

Abstract

Pasar modal sebagai salah satu instrumen ekonomi tidak terlepas dari pengaruh lingkungan, baik lingkungan ekonomi maupun lingkungan non-ekonomi. Peristiwa politik merupakan salah satu risiko non-ekonomi yang dapat mempengaruhi keputusan investor untuk berinvestasi di pasar modal. Tujuan artikel ini untuk mengetahui pengaruh pemilu presiden Indonesia tahun 2019 terhadap return saham ketika akan ditentukannya bakal calon presiden sebelum pelaksanaan pemilihan umum presiden, pada saat pelaksanaan, dan juga sesudah pelaksanaannya terhadap saham-saham yang terdaftar didalam indeks JII70. Populasi dalam penelitian ini adalah perusahaan yang sahamnya tercatat didalam indeks JII70. Penelitian ini menggunakan even study (studi peristiwa). Hasil penelitian menunjukkan bahwa ada reaksi investor di mana 7 hari sebelum dan 7 hari sesudah tanggal 17 April 2019 pemilu serentak. Penelitian ini menunjukkan bahwa peristiwa pemilu presiden pada tahun 2019 menunjukkan hasil yang cukup signifikan terhadap return dan harga saham dibeberapa perusahaan yang tergabung di indeks JII70. Kata Kunci: Pasar Modal, Return, Pemilu Presiden.
PERBANDINGAN KINERJA KEUANGAN PERUSAHAAN FARMASI MILIK BUMN DAN SWASTA DI BEI PERIODE 2016-2018 Candrayani, Lia; Fitri, Ziana; Fadlullah Hana, Kharis
Mabsya: Jurnal Manajemen Bisnis Syariah Vol 2 No 1 (2020): Mabsya: Jurnal Manajemen Bisnis Syariah
Publisher : Fakultas Ekonomi dan Bisnis Islam Institut Agama Islam Negeri (IAIN) Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24090/mabsya.v2i1.3877

Abstract

The purpose of this study was to determine the comparison of the financial performance of state-owned pharmaceutical companies with private-owned pharmaceutical companies and find out what factors affect differences in company performance based on analysis of profitability, market value rations and EVA. This study using a quantitative approach using a comparative descriptive method that took a sample of 4 pharmaceutical companies listed on the Stock Excahange. The data analysis technique uses a different independent sample T-test by comparing financial data from state-owned and private pharmaceutical companies in the 2016-2018 period. The results of the study show that return on equity (ROE) analysis of state-owned pharmaceutical companies is not safe because there are significant differences in the precentage above 15% and private pharmaceutical above 15%. The earning per share (EPS) analysis results of state-owned companies reached 0,35 and private pharmaceutical companies reached 50,71. As well as economic value added (EVA) analysis produces data there are differences in financial performace where the state-owned pharmaceutical companies have increased and privat pharmaceutical companies have decreased.
Perbandingan Kinerja Keuangan Perusahaan Farmasi Milik BUMN dan Swasta di BEI Periode 2016-2018 Candrayani, Lia; Fitri, Ziana; Fadlullah Hana, Kharis
Mabsya: Jurnal Manajemen Bisnis Syariah Vol 2 No 1 (2020): Mabsya: Jurnal Manajemen Bisnis Syariah
Publisher : Fakultas Ekonomi dan Bisnis Islam Institut Agama Islam Negeri (IAIN) Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24090/mabsya.v2i1.3877

Abstract

The purpose of this study was to determine the comparison of the financial performance of state-owned pharmaceutical companies with private-owned pharmaceutical companies and find out what factors affect differences in company performance based on analysis of profitability, market value rations and EVA. This study using a quantitative approach using a comparative descriptive method that took a sample of 4 pharmaceutical companies listed on the Stock Excahange. The data analysis technique uses a different independent sample T-test by comparing financial data from state-owned and private pharmaceutical companies in the 2016-2018 period. The results of the study show that return on equity (ROE) analysis of state-owned pharmaceutical companies is not safe because there are significant differences in the precentage above 15% and private pharmaceutical above 15%. The earning per share (EPS) analysis results of state-owned companies reached 0,35 and private pharmaceutical companies reached 50,71. As well as economic value added (EVA) analysis produces data there are differences in financial performace where the state-owned pharmaceutical companies have increased and privat pharmaceutical companies have decreased.
Co-Authors Adevia Fendiyani, Erika Candrayani, Lia Fitri, Ziana Handayani, Asih Zulia Kunthi, Dewi